TAXIS Pharmaceuticals, Inc.

TAXIS Pharmaceuticals, Inc.

Specialty Pharma
BioNJ Member Type: Core

TAXIS, a Delaware-based subchapter S corporation with operations in New Jersey, was formed in March, 2009 by the two scientific founders – Ed LaVoie, Chair of the Department of Medicinal Chemistry, Rutgers and Dani Pilch, Associate Professor of Pharmacology, UMDNJ – and the chief executive officer, Gregory G. Mario. TAXIS is focusing its current efforts on developing the azachryseniums (AZCs) as a novel class of bactericidal agents that can effectively treat infections caused by MDR bacterial pathogens.


NJ Technology Center 675 US Highway One
North Brunswick, NJ 08902